Cancer drugs and copayments

Paradox of complementary medicine

BMJ 2008; 337 doi: 10.1136/bmj.a897 (Published 22 July 2008)
Cite this as: BMJ 2008;337:a897

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John Doherty, medical director
  1. 1IAEA, Vienna 1400, Austria
  1. dr.johndoherty{at}gmail.com

    Finlay and Crisp do not resolve the paradox that continued NHS cancer treatment …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL